80 related articles for article (PubMed ID: 27736013)
1. IGFBP3 and MAPK/ERK signaling mediates melatonin-induced antitumor activity in prostate cancer.
Mayo JC; Hevia D; Quiros-Gonzalez I; Rodriguez-Garcia A; Gonzalez-Menendez P; Cepas V; Gonzalez-Pola I; Sainz RM
J Pineal Res; 2017 Jan; 62(1):. PubMed ID: 27736013
[TBL] [Abstract][Full Text] [Related]
2. Systemic Ablation of
Pulliam TL; Awad D; Han JJ; Murray MM; Ackroyd JJ; Goli P; Oakhill JS; Scott JW; Ittmann MM; Frigo DE
Cells; 2022 Jun; 11(12):. PubMed ID: 35741020
[TBL] [Abstract][Full Text] [Related]
3. The effects of glycemic index on prostate cancer progression in a xenograft mouse model.
Galván GC; Macias E; Sanders S; Ramirez-Torres A; Stock S; You S; Riera CE; Tamukong P; Smith-Warner SA; Genkinger JM; Luthringer DJ; Freeman MR; Freedland SJ
Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):348-354. PubMed ID: 38082056
[TBL] [Abstract][Full Text] [Related]
4. CDK12 regulates angiogenesis of advanced prostate cancer by IGFBP3.
Zhong K; Luo W; Li N; Tan X; Li Y; Yin S; Huang Y; Fang L; Ma W; Cai Y; Yin Y
Int J Oncol; 2024 Feb; 64(2):. PubMed ID: 38186306
[TBL] [Abstract][Full Text] [Related]
5. Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment.
Zharinov GM; Bogomolov OA; Chepurnaya IV; Neklasova NY; Anisimov VN
Oncotarget; 2020 Oct; 11(41):3723-3729. PubMed ID: 33110479
[TBL] [Abstract][Full Text] [Related]
6. Melatonin Decreases Glucose Metabolism in Prostate Cancer Cells: A
Hevia D; Gonzalez-Menendez P; Fernandez-Fernandez M; Cueto S; Rodriguez-Gonzalez P; Garcia-Alonso JI; Mayo JC; Sainz RM
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28933733
[TBL] [Abstract][Full Text] [Related]
7. Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways.
Gao Y; Xiao X; Zhang C; Yu W; Guo W; Zhang Z; Li Z; Feng X; Hao J; Zhang K; Xiao B; Chen M; Huang W; Xiong S; Wu X; Deng W
J Pineal Res; 2017 Mar; 62(2):. PubMed ID: 27865009
[TBL] [Abstract][Full Text] [Related]
8. Melatonin and sirtuins: A "not-so unexpected" relationship.
Mayo JC; Sainz RM; González Menéndez P; Cepas V; Tan DX; Reiter RJ
J Pineal Res; 2017 Mar; 62(2):. PubMed ID: 28109165
[TBL] [Abstract][Full Text] [Related]
9. KRAS mutation coupled with p53 loss is sufficient to induce ovarian carcinosarcomas in mice.
Tang FH; Hsieh TH; Hsu CY; Lin HY; Long CY; Cheng KH; Tsai EM
Int J Cancer; 2017 Apr; 140(8):1860-1869. PubMed ID: 28032649
[TBL] [Abstract][Full Text] [Related]
10. Melatonin and the pathologies of weakened or dysregulated circadian oscillators.
Hardeland R
J Pineal Res; 2017 Jan; 62(1):. PubMed ID: 27763686
[TBL] [Abstract][Full Text] [Related]
11. Melatonin Analogue Antiproliferative and Cytotoxic Effects on Human Prostate Cancer Cells.
Calastretti A; Gatti G; Lucini V; Dugnani S; Canti G; Scaglione F; Bevilacqua A
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783631
[TBL] [Abstract][Full Text] [Related]
12. Melatonin Inhibits Androgen Receptor Splice Variant-7 (AR-V7)-Induced Nuclear Factor-Kappa B (NF-κB) Activation and NF-κB Activator-Induced AR-V7 Expression in Prostate Cancer Cells: Potential Implications for the Use of Melatonin in Castration-Resistant Prostate Cancer (CRPC) Therapy.
Liu VWS; Yau WL; Tam CW; Yao KM; Shiu SYW
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28561752
[TBL] [Abstract][Full Text] [Related]
13. Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.
Reiter RJ; Rosales-Corral SA; Tan DX; Acuna-Castroviejo D; Qin L; Yang SF; Xu K
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420185
[TBL] [Abstract][Full Text] [Related]
14. Melatonin and Cancer Hallmarks.
Talib WH
Molecules; 2018 Feb; 23(3):. PubMed ID: 29495398
[TBL] [Abstract][Full Text] [Related]
15. Melatonin and breast cancer: Evidences from preclinical and human studies.
Kubatka P; Zubor P; Busselberg D; Kwon TK; Adamek M; Petrovic D; Opatrilova R; Gazdikova K; Caprnda M; Rodrigo L; Danko J; Kruzliak P
Crit Rev Oncol Hematol; 2018 Feb; 122():133-143. PubMed ID: 29458781
[TBL] [Abstract][Full Text] [Related]
16. Melatonin for the prevention and treatment of cancer.
Li Y; Li S; Zhou Y; Meng X; Zhang JJ; Xu DP; Li HB
Oncotarget; 2017 Jun; 8(24):39896-39921. PubMed ID: 28415828
[TBL] [Abstract][Full Text] [Related]
17. Melatonin-Induced Cytoskeleton Reorganization Leads to Inhibition of Melanoma Cancer Cell Proliferation.
Alvarez-Artime A; Cernuda-Cernuda R; Francisco-Artime-Naveda ; Cepas V; Gonzalez-Menendez P; Fernadez-Vega S; Quiros-Gonzalez I; Sainz RM; Mayo JC
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952224
[TBL] [Abstract][Full Text] [Related]
18. Transdermal administration of melatonin coupled to cryopass laser treatment as noninvasive therapy for prostate cancer.
Terraneo L; Bianciardi P; Virgili E; Finati E; Samaja M; Paroni R
Drug Deliv; 2017 Nov; 24(1):979-985. PubMed ID: 28644090
[TBL] [Abstract][Full Text] [Related]
19. Thioredoxin 1 modulates apoptosis induced by bioactive compounds in prostate cancer cells.
Rodriguez-Garcia A; Hevia D; Mayo JC; Gonzalez-Menendez P; Coppo L; Lu J; Holmgren A; Sainz RM
Redox Biol; 2017 Aug; 12():634-647. PubMed ID: 28391184
[TBL] [Abstract][Full Text] [Related]
20. IGFBP3 Enhances Treatment Outcome and Predicts Favorable Prognosis in ABC-DLBCL.
Li HB; Wang D; Zhang Y; Shen D; Che YQ
J Oncol; 2023; 2023():1388041. PubMed ID: 36660244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
